| ADCC | Antibody-dependent cellular cytotoxicity |
| ALL | Acute lymphoblastic leukemia |
| AML | Acute myeloic leukemia |
| Ank | Ankylosis |
| BCSP | Bone cartilage, stromal progenitor |
| BFU-E | erythroid burst-forming unit(s) |
| BL-CFC | Blast-colony forming cell(s) |
| BMP | Bone morphogenetic protein |
| ccp | Clathrin-coated pits |
| CFU-E | Erythroid colony forming unit(s) |
| CFU-GM | Granulocyte-macrophage colony-forming unit(s) |
| E | Embryonic day |
| EC(s) | Endothelial cell(s) |
| EEA-1 | Early endosomal antigen-1 |
| Eng | Gene encoding Endoglin |
| EryP | Early erythroid precursor(s) |
| ES | Embryonic stem cell(s) |
| FACS | Fluorescence-activated cell sorting |
| Flk-1 | Fetal liver kinase-1 |
| GIPC | GAIP C-terminus-interacting protein |
| HHT-1 | Hereditary hemorrhagic telangiectasia-1 |
| HSC | Hematopoietic stem cell(s) |
| HUVECs | Human umbilical vein endothelial cells |
| iNOS | Inducible NO-synthase |
| IR | Intron retention |
| IUPR | Intrauterine growth restriction |
| L-Eng | Long form of Endoglin |
| mASC | Murine adipose tissue derived MSC |
| MC(s) | Mast cell(s) |
| MEP | Megakaryocyte-erythroid progenitor(s) |
| MPP | Multipotent progenitor(s) |
| MSC(s) | Mesenchymal stem cell(s) |
| pERK1/2 | Phosphorylated extracellular signal-regulated kinase 1/2 |
| PI3K/Akt | Phosphatidylinositol 3-kinase |
| PMA | Phorbol-12-myristate-13-acetate |
| PMN | Polymorphonuclear neutrophils |
| sEng | Soluble Endoglin |
| sFlt-1 | Soluble fms-like tyrosine kinase-1 (VEGF recptor) |
| S-Eng | Short variant of Endoglin |
| sVEGFR1 | Soluble VEGF receptor |
| TβRI/II | Transforming growth factor-β1 type I or II receptor |
| ZRP-1 | Zyxin-related protein (ZRP)-1 |